Supervised, individualised exercise reduces fatigue and improves strength and quality of life more than unsupervised home exercise in people with chronic Guillain-Barré syndrome: a randomised trial.

This trial looked at people who were in the long-term, stable phase of Guillain-Barré syndrome, meaning at least six months had passed since their symptoms began and their disability had settled into a fairly steady pattern. Sixteen adults were randomly assigned to either a supervised, individualised exercise program run by a physiotherapist (strengthening, endurance work, breathing exercises, gait training, and pain management, done two to three times a week for 12 weeks in 60-minute sessions) or a home-based program of shorter maintenance exercises and self-management education on a similar schedule. The researchers were mainly interested in whether the supervised program helped people do daily activities more independently, measured on the 100-point Barthel Index, and they also tracked muscle strength, fatigue, pain, and quality of life at 6 and 12 months. At six months, the supervised group showed somewhat greater improvements across several measures, including functional independence, muscle strength, reduced fatigue, and one aspect of quality of life related to environment.

By 12 months the differences were similar in size but the confidence intervals were wider, meaning the results were less precise and less certain over the longer term. With only 16 participants, these findings should be read as an early signal rather than a settled answer, but they do suggest that closer, individualised supervision may offer some real advantages over a more generic home program in this population.

This study followed adults who had been living with the after-effects of Guillain-Barré syndrome for at least six months, comparing two types of exercise programs over 12 weeks. One group did longer, one-on-one sessions with a physiotherapist that included strength work, endurance training, breathing exercises, walking practice, and pain management.

The other group followed a shorter home exercise routine along with education on managing their own symptoms. At the six-month mark, people in the supervised program showed somewhat better results in daily activity independence, muscle strength, tiredness levels, and one part of quality of life connected to their living environment. The fatigue improvement was a specific and reassuring finding, since ongoing tiredness is such a common and frustrating part of life after GBS.

By the one-year mark, the differences between the two groups were roughly similar in size, but the results were less precise, so it is harder to say how confident we can be about what happens further out. Because this study only included 16 people, the findings give an early hint rather than a firm conclusion. It does suggest that the amount and structure of exercise support someone receives during the chronic phase of GBS might make a meaningful difference to how they feel and function, though larger studies would help confirm this.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This was a small but methodologically careful randomised trial (concealed allocation, intention-to-treat analysis, blinded outcome assessors) comparing a 12-week supervised, individualised exercise program against a home-based maintenance program in 16 adults with chronic, stable GBS-related disability. The supervised arm involved longer sessions (60 minutes versus 30) incorporating strengthening, endurance, breathing work, gait training, and pain management, delivered at a similar frequency to the home program (two to three sessions weekly). At six months, the supervised group showed greater improvements on the Barthel Index, MRC strength scale, Fatigue Severity Scale, and the environment domain of a quality-of-life measure, with confidence intervals that excluded no difference for most outcomes.

By 12 months the point estimates were of similar magnitude, but wider confidence intervals reflected greater uncertainty, which may relate to the small sample size and possible loss of intervention effect or adherence over time. Given the sample size of only 16 participants, these results should be interpreted as preliminary rather than conclusive, and replication in larger cohorts would help clarify how durable these between-group differences are beyond six months. The trial does add specific, controlled evidence to a chronic GBS population that is often underrepresented in rehabilitation research.